# Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina

Study · id `cardio:ct-nct01396395` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01396395](<https://clinicaltrials.gov/study/NCT01396395>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01396395

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 402 participants.

## Technical summary

Registry record NCT01396395. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2016-04-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 402 participants (enrolled count; ClinicalTrials.gov record NCT01396395, source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)
- Start date: 2011-09 (registry gives no type) (ClinicalTrials.gov record NCT01396395, source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01396395, source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)
- Completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01396395, source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)
- Results first posted: 2016-04-14 (ClinicalTrials.gov record NCT01396395, source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01396395, source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01396395-2016-04-14`, retrieved 2026-10-31)

## The registry's words

- Brief title: Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
- Acronym: SIGMART
- Condition: Stable Angina
- Condition: Coronary Disease
- Intervention (Drug): Nicorandil
- Intervention (Drug): Standard Treatment
- Lead sponsor: Merck KGaA, Darmstadt, Germany
- Lead sponsor class: INDUSTRY
- Collaborator: Merck Serono Co., Ltd., China
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Merck KGaA, Darmstadt, Germany (`cardio:org-merck-kgaa-darmstadt-germany`)
- Registry lists this organization as a collaborator: Merck Serono Co., Ltd., China (`cardio:org-merck-serono-co-ltd-china`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study (`cardio:pubmed-27657471`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 18d0692890ea86a04a1b6fe64e466580c6083106ef7cfac7bdd87c5dcfc3603b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
